Landscapes / Companies
IDEAYA Biosciences not checked
FollowEvery new trial, moved date and filing, and a Monday email
Drugs
7
in active trials
Trials
11 active
11 since 2021
Drugs7
| Drug | How it works | Partner | Stage
Sources: FDA: the drug development process, ClinicalTrials.gov glossary | Next date
| Details |
|---|---|---|---|---|---|
— |
Phase 3 | 15 Jan 2027Phase 2/3 trial completes | |||
| Next date | 15 Jan 2027 · Phase 2/3 trial completes | ||||
| Also tested for | Uveal Melanoma, Metastatic Uveal Melanoma and 3 more | ||||
| Open drug page | |||||
— |
Phase 1/2 | Jul 2029Phase 1/2 trial completes | |||
| Next date | Jul 2029 · Phase 1/2 trial completes | ||||
| Also tested for | Advanced or Metastatic Solid Tumors, Breast Cancer and 10 more | ||||
| Open drug page | |||||
— |
Phase 1/2 | Jul 2029Phase 1/2 trial completes | |||
| Next date | Jul 2029 · Phase 1/2 trial completes | ||||
| Also tested for | Small-cell Lung Cancer, Neuroendocrine Carcinomas and 1 more | ||||
| Open drug page | |||||
— |
Phase 1 | 7 Jan 2027Phase 1 trial completes | |||
| Next date | 7 Jan 2027 · Phase 1 trial completes | ||||
| Also tested for | Solid Tumor, NSCLC Adenocarcinoma and 12 more | ||||
| Open drug page | |||||
— |
Phase 1 | 30 Jul 2027Phase 1 trial completes | |||
| Next date | 30 Jul 2027 · Phase 1 trial completes | ||||
| Also tested for | Esophageal Squamous Cell Carcinoma, High Grade Serous Ovarian Cancer and 6 more | ||||
| Open drug page | |||||
— |
Phase 1 | 30 Apr 2028Phase 1 trial completes | |||
| Next date | 30 Apr 2028 · Phase 1 trial completes | ||||
| Also tested for | NSCLC Adenocarcinoma, Gastroesophageal Cancer (GC) and 11 more | ||||
| Open drug page | |||||
— |
Phase 1 | 31 Dec 2029Phase 1 trial completes | |||
| Next date | 31 Dec 2029 · Phase 1 trial completes | ||||
| Also tested for | Cancer | ||||
| Open drug page | |||||
About
- SEC filings
- None: it does not file with the US SEC
- Sources
- ClinicalTrials.gov updated 18 Nov 2026 Industry-sponsored drug trials since 2021